Index by author
February 01, 2017; Volume 360,Issue 2
A
Abbadie, C.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Abeywardena, Mahinda Yapa
- Open AccessEffects of Antihypertensive Agents on Intestinal Contractility in the Spontaneously Hypertensive Rat: Angiotensin Receptor System Downregulation by LosartanGlen Stephen Patten and Mahinda Yapa AbeywardenaJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 260-266; DOI: https://doi.org/10.1124/jpet.116.237586
Ahmed, Aamir
- Open AccessIntracellular Calcium Mobilization in Response to Ion Channel Regulators via a Calcium-Induced Calcium Release MechanismTerry Petrou, Hervør L. Olsen, Christopher Thrasivoulou, John R. Masters, Jonathan F. Ashmore and Aamir AhmedJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 378-387; DOI: https://doi.org/10.1124/jpet.116.236695
Aiello, Robert J.
- You have accessTryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary HypertensionRobert J. Aiello, Patricia-Ann Bourassa, Qing Zhang, Jeffrey Dubins, Daniel R. Goldberg, Stéphane De Lombaert, Marc Humbert, Christophe Guignabert, Maria A. Cavasin, Timothy A. McKinsey and Vishwas ParalkarJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 267-279; DOI: https://doi.org/10.1124/jpet.116.237933
Albert, Christopher
- You have accessResponse to “Tenofovir Disoproxil Fumarate Is Not an Inhibitor of Human Organic Cation Transporter 1”Gerard Minuesa, Christopher Albert, Marçal Pastor-Anglada, Javier Martinez-Picado and Hermann KoepsellJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 343-345; DOI: https://doi.org/10.1124/jpet.116.239004
Ashmore, Jonathan F.
- Open AccessIntracellular Calcium Mobilization in Response to Ion Channel Regulators via a Calcium-Induced Calcium Release MechanismTerry Petrou, Hervør L. Olsen, Christopher Thrasivoulou, John R. Masters, Jonathan F. Ashmore and Aamir AhmedJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 378-387; DOI: https://doi.org/10.1124/jpet.116.236695
B
Bartol, Anna
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
Beil, Michael
- You have accessCharacterization and Prediction of Cardiovascular Effects of Fingolimod and Siponimod Using a Systems Pharmacology Modeling ApproachNelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Dean F. Rigel, Randy L. Webb, David Feldman, Fumin Fu, Michael Beil, Liang Jin, Donald R. Stanski and Meindert DanhofJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 356-367; DOI: https://doi.org/10.1124/jpet.116.236208
Bödefeld, Theresa
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
Bourassa, Patricia-Ann
- You have accessTryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary HypertensionRobert J. Aiello, Patricia-Ann Bourassa, Qing Zhang, Jeffrey Dubins, Daniel R. Goldberg, Stéphane De Lombaert, Marc Humbert, Christophe Guignabert, Maria A. Cavasin, Timothy A. McKinsey and Vishwas ParalkarJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 267-279; DOI: https://doi.org/10.1124/jpet.116.237933
Butt, Mark
- You have accessReveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe DiseaseJeffrey Peng, Jill Dalton, Mark Butt, Kristin Tracy, Derek Kennedy, Peter Haroldsen, Rhea Cahayag, Stephen Zoog, Charles A. O’Neill and Laurie S. TsurudaJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 313-323; DOI: https://doi.org/10.1124/jpet.116.235952
C
Cahayag, Rhea
- You have accessReveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe DiseaseJeffrey Peng, Jill Dalton, Mark Butt, Kristin Tracy, Derek Kennedy, Peter Haroldsen, Rhea Cahayag, Stephen Zoog, Charles A. O’Neill and Laurie S. TsurudaJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 313-323; DOI: https://doi.org/10.1124/jpet.116.235952
Cavasin, Maria A.
- You have accessTryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary HypertensionRobert J. Aiello, Patricia-Ann Bourassa, Qing Zhang, Jeffrey Dubins, Daniel R. Goldberg, Stéphane De Lombaert, Marc Humbert, Christophe Guignabert, Maria A. Cavasin, Timothy A. McKinsey and Vishwas ParalkarJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 267-279; DOI: https://doi.org/10.1124/jpet.116.237933
Chatterjee, Mitali
- You have accessAllylpyrocatechol Attenuates Collagen-Induced Arthritis via Attenuation of Oxidative Stress Secondary to Modulation of the MAPK, JAK/STAT, and Nrf2/HO-1 PathwaysSoumita De, Alak Manna, Sunanda Kundu, Sritama De Sarkar, Uttara Chatterjee, Tuhinadri Sen, Subrata Chattopadhyay and Mitali ChatterjeeJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 249-259; DOI: https://doi.org/10.1124/jpet.116.238444
Chatterjee, Uttara
- You have accessAllylpyrocatechol Attenuates Collagen-Induced Arthritis via Attenuation of Oxidative Stress Secondary to Modulation of the MAPK, JAK/STAT, and Nrf2/HO-1 PathwaysSoumita De, Alak Manna, Sunanda Kundu, Sritama De Sarkar, Uttara Chatterjee, Tuhinadri Sen, Subrata Chattopadhyay and Mitali ChatterjeeJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 249-259; DOI: https://doi.org/10.1124/jpet.116.238444
Chattopadhyay, Subrata
- You have accessAllylpyrocatechol Attenuates Collagen-Induced Arthritis via Attenuation of Oxidative Stress Secondary to Modulation of the MAPK, JAK/STAT, and Nrf2/HO-1 PathwaysSoumita De, Alak Manna, Sunanda Kundu, Sritama De Sarkar, Uttara Chatterjee, Tuhinadri Sen, Subrata Chattopadhyay and Mitali ChatterjeeJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 249-259; DOI: https://doi.org/10.1124/jpet.116.238444
D
Dahal, Sujata
- You have accessBehavioral Characterization of κ Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in RatsVanessa Minervini, Sujata Dahal and Charles P. FranceJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 280-287; DOI: https://doi.org/10.1124/jpet.116.235630
Dalton, Jill
- You have accessReveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe DiseaseJeffrey Peng, Jill Dalton, Mark Butt, Kristin Tracy, Derek Kennedy, Peter Haroldsen, Rhea Cahayag, Stephen Zoog, Charles A. O’Neill and Laurie S. TsurudaJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 313-323; DOI: https://doi.org/10.1124/jpet.116.235952
Danhof, Meindert
- You have accessCharacterization and Prediction of Cardiovascular Effects of Fingolimod and Siponimod Using a Systems Pharmacology Modeling ApproachNelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Dean F. Rigel, Randy L. Webb, David Feldman, Fumin Fu, Michael Beil, Liang Jin, Donald R. Stanski and Meindert DanhofJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 356-367; DOI: https://doi.org/10.1124/jpet.116.236208
De, Soumita
- You have accessAllylpyrocatechol Attenuates Collagen-Induced Arthritis via Attenuation of Oxidative Stress Secondary to Modulation of the MAPK, JAK/STAT, and Nrf2/HO-1 PathwaysSoumita De, Alak Manna, Sunanda Kundu, Sritama De Sarkar, Uttara Chatterjee, Tuhinadri Sen, Subrata Chattopadhyay and Mitali ChatterjeeJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 249-259; DOI: https://doi.org/10.1124/jpet.116.238444
DeAmici, Marco
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
De Lombaert, Stéphane
- You have accessTryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary HypertensionRobert J. Aiello, Patricia-Ann Bourassa, Qing Zhang, Jeffrey Dubins, Daniel R. Goldberg, Stéphane De Lombaert, Marc Humbert, Christophe Guignabert, Maria A. Cavasin, Timothy A. McKinsey and Vishwas ParalkarJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 267-279; DOI: https://doi.org/10.1124/jpet.116.237933
DeMartino, J. A.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
De Sarkar, Sritama
- You have accessAllylpyrocatechol Attenuates Collagen-Induced Arthritis via Attenuation of Oxidative Stress Secondary to Modulation of the MAPK, JAK/STAT, and Nrf2/HO-1 PathwaysSoumita De, Alak Manna, Sunanda Kundu, Sritama De Sarkar, Uttara Chatterjee, Tuhinadri Sen, Subrata Chattopadhyay and Mitali ChatterjeeJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 249-259; DOI: https://doi.org/10.1124/jpet.116.238444
Dhopeshwarkar, Amey
- You have accessTwo Janus Cannabinoids That Are Both CB2 Agonists and CB1 AntagonistsAmey Dhopeshwarkar, Natalia Murataeva, Alex Makriyannis, Alex Straiker and Ken MackieJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 300-311; DOI: https://doi.org/10.1124/jpet.116.236539
Di Salvo, J.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Donnelly, M. J.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Dubins, Jeffrey
- You have accessTryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary HypertensionRobert J. Aiello, Patricia-Ann Bourassa, Qing Zhang, Jeffrey Dubins, Daniel R. Goldberg, Stéphane De Lombaert, Marc Humbert, Christophe Guignabert, Maria A. Cavasin, Timothy A. McKinsey and Vishwas ParalkarJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 267-279; DOI: https://doi.org/10.1124/jpet.116.237933
E
Edmondson, S. D.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Etscheid, Justine
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
F
Feldman, David
- You have accessCharacterization and Prediction of Cardiovascular Effects of Fingolimod and Siponimod Using a Systems Pharmacology Modeling ApproachNelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Dean F. Rigel, Randy L. Webb, David Feldman, Fumin Fu, Michael Beil, Liang Jin, Donald R. Stanski and Meindert DanhofJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 356-367; DOI: https://doi.org/10.1124/jpet.116.236208
Fitzmaurice, A.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Fleischmann, Bernd K.
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
France, Charles P.
- You have accessBehavioral Characterization of κ Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in RatsVanessa Minervini, Sujata Dahal and Charles P. FranceJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 280-287; DOI: https://doi.org/10.1124/jpet.116.235630
Frenkl, T.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Fu, Fumin
- You have accessCharacterization and Prediction of Cardiovascular Effects of Fingolimod and Siponimod Using a Systems Pharmacology Modeling ApproachNelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Dean F. Rigel, Randy L. Webb, David Feldman, Fumin Fu, Michael Beil, Liang Jin, Donald R. Stanski and Meindert DanhofJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 356-367; DOI: https://doi.org/10.1124/jpet.116.236208
G
Ganey, Patricia E.
- You have accessIdiosyncratic Drug-Induced Liver Injury: Is Drug-Cytokine Interaction the Linchpin?Robert A. Roth, Ashley R. Maiuri and Patricia E. GaneyJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 368-377; DOI: https://doi.org/10.1124/jpet.116.237578
Gichuru, L.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Giembycz, Mark A.
- You have accessGS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial CellsTaruna Joshi, Dong Yan, Omar Hamed, Stacey L. Tannheimer, Gary B. Phillips, Clifford D. Wright, Musong Kim, Michael Salmon, Robert Newton and Mark A. GiembyczJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 324-340; DOI: https://doi.org/10.1124/jpet.116.237743
Goldberg, Daniel R.
- You have accessTryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary HypertensionRobert J. Aiello, Patricia-Ann Bourassa, Qing Zhang, Jeffrey Dubins, Daniel R. Goldberg, Stéphane De Lombaert, Marc Humbert, Christophe Guignabert, Maria A. Cavasin, Timothy A. McKinsey and Vishwas ParalkarJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 267-279; DOI: https://doi.org/10.1124/jpet.116.237933
Guignabert, Christophe
- You have accessTryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary HypertensionRobert J. Aiello, Patricia-Ann Bourassa, Qing Zhang, Jeffrey Dubins, Daniel R. Goldberg, Stéphane De Lombaert, Marc Humbert, Christophe Guignabert, Maria A. Cavasin, Timothy A. McKinsey and Vishwas ParalkarJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 267-279; DOI: https://doi.org/10.1124/jpet.116.237933
H
Hamed, Omar
- You have accessGS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial CellsTaruna Joshi, Dong Yan, Omar Hamed, Stacey L. Tannheimer, Gary B. Phillips, Clifford D. Wright, Musong Kim, Michael Salmon, Robert Newton and Mark A. GiembyczJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 324-340; DOI: https://doi.org/10.1124/jpet.116.237743
Haroldsen, Peter
- You have accessReveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe DiseaseJeffrey Peng, Jill Dalton, Mark Butt, Kristin Tracy, Derek Kennedy, Peter Haroldsen, Rhea Cahayag, Stephen Zoog, Charles A. O’Neill and Laurie S. TsurudaJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 313-323; DOI: https://doi.org/10.1124/jpet.116.235952
Holzgrabe, Ulrike
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
Humbert, Marc
- You have accessTryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary HypertensionRobert J. Aiello, Patricia-Ann Bourassa, Qing Zhang, Jeffrey Dubins, Daniel R. Goldberg, Stéphane De Lombaert, Marc Humbert, Christophe Guignabert, Maria A. Cavasin, Timothy A. McKinsey and Vishwas ParalkarJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 267-279; DOI: https://doi.org/10.1124/jpet.116.237933
Humphreys, W. Griffith
- You have accessTenofovir Disoproxil Fumarate Is Not an Inhibitor of Human Organic Cation Transporter 1Hong Shen, Wenying Li, W. Griffith Humphreys and Yurong LaiJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 341-342; DOI: https://doi.org/10.1124/jpet.116.238337
Hurley, A. L.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
J
Jin, Liang
- You have accessCharacterization and Prediction of Cardiovascular Effects of Fingolimod and Siponimod Using a Systems Pharmacology Modeling ApproachNelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Dean F. Rigel, Randy L. Webb, David Feldman, Fumin Fu, Michael Beil, Liang Jin, Donald R. Stanski and Meindert DanhofJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 356-367; DOI: https://doi.org/10.1124/jpet.116.236208
Jochnowitz, N.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Joshi, Taruna
- You have accessGS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial CellsTaruna Joshi, Dong Yan, Omar Hamed, Stacey L. Tannheimer, Gary B. Phillips, Clifford D. Wright, Musong Kim, Michael Salmon, Robert Newton and Mark A. GiembyczJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 324-340; DOI: https://doi.org/10.1124/jpet.116.237743
K
Kennedy, Derek
- You have accessReveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe DiseaseJeffrey Peng, Jill Dalton, Mark Butt, Kristin Tracy, Derek Kennedy, Peter Haroldsen, Rhea Cahayag, Stephen Zoog, Charles A. O’Neill and Laurie S. TsurudaJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 313-323; DOI: https://doi.org/10.1124/jpet.116.235952
Kim, Musong
- You have accessGS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial CellsTaruna Joshi, Dong Yan, Omar Hamed, Stacey L. Tannheimer, Gary B. Phillips, Clifford D. Wright, Musong Kim, Michael Salmon, Robert Newton and Mark A. GiembyczJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 324-340; DOI: https://doi.org/10.1124/jpet.116.237743
Klöckner, Jessica
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
Koepsell, Hermann
- You have accessResponse to “Tenofovir Disoproxil Fumarate Is Not an Inhibitor of Human Organic Cation Transporter 1”Gerard Minuesa, Christopher Albert, Marçal Pastor-Anglada, Javier Martinez-Picado and Hermann KoepsellJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 343-345; DOI: https://doi.org/10.1124/jpet.116.239004
Kostenis, Evi
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
Kulick, A.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Kundu, Sunanda
- You have accessAllylpyrocatechol Attenuates Collagen-Induced Arthritis via Attenuation of Oxidative Stress Secondary to Modulation of the MAPK, JAK/STAT, and Nrf2/HO-1 PathwaysSoumita De, Alak Manna, Sunanda Kundu, Sritama De Sarkar, Uttara Chatterjee, Tuhinadri Sen, Subrata Chattopadhyay and Mitali ChatterjeeJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 249-259; DOI: https://doi.org/10.1124/jpet.116.238444
L
Lai, Yurong
- You have accessTenofovir Disoproxil Fumarate Is Not an Inhibitor of Human Organic Cation Transporter 1Hong Shen, Wenying Li, W. Griffith Humphreys and Yurong LaiJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 341-342; DOI: https://doi.org/10.1124/jpet.116.238337
Li, Wenying
- You have accessTenofovir Disoproxil Fumarate Is Not an Inhibitor of Human Organic Cation Transporter 1Hong Shen, Wenying Li, W. Griffith Humphreys and Yurong LaiJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 341-342; DOI: https://doi.org/10.1124/jpet.116.238337
Luttringer, Olivier
- You have accessCharacterization and Prediction of Cardiovascular Effects of Fingolimod and Siponimod Using a Systems Pharmacology Modeling ApproachNelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Dean F. Rigel, Randy L. Webb, David Feldman, Fumin Fu, Michael Beil, Liang Jin, Donald R. Stanski and Meindert DanhofJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 356-367; DOI: https://doi.org/10.1124/jpet.116.236208
M
Mackie, Ken
- You have accessTwo Janus Cannabinoids That Are Both CB2 Agonists and CB1 AntagonistsAmey Dhopeshwarkar, Natalia Murataeva, Alex Makriyannis, Alex Straiker and Ken MackieJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 300-311; DOI: https://doi.org/10.1124/jpet.116.236539
Maiuri, Ashley R.
- You have accessIdiosyncratic Drug-Induced Liver Injury: Is Drug-Cytokine Interaction the Linchpin?Robert A. Roth, Ashley R. Maiuri and Patricia E. GaneyJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 368-377; DOI: https://doi.org/10.1124/jpet.116.237578
Makriyannis, Alex
- You have accessTwo Janus Cannabinoids That Are Both CB2 Agonists and CB1 AntagonistsAmey Dhopeshwarkar, Natalia Murataeva, Alex Makriyannis, Alex Straiker and Ken MackieJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 300-311; DOI: https://doi.org/10.1124/jpet.116.236539
Manna, Alak
- You have accessAllylpyrocatechol Attenuates Collagen-Induced Arthritis via Attenuation of Oxidative Stress Secondary to Modulation of the MAPK, JAK/STAT, and Nrf2/HO-1 PathwaysSoumita De, Alak Manna, Sunanda Kundu, Sritama De Sarkar, Uttara Chatterjee, Tuhinadri Sen, Subrata Chattopadhyay and Mitali ChatterjeeJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 249-259; DOI: https://doi.org/10.1124/jpet.116.238444
Martinez-Picado, Javier
- You have accessResponse to “Tenofovir Disoproxil Fumarate Is Not an Inhibitor of Human Organic Cation Transporter 1”Gerard Minuesa, Christopher Albert, Marçal Pastor-Anglada, Javier Martinez-Picado and Hermann KoepsellJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 343-345; DOI: https://doi.org/10.1124/jpet.116.239004
Masters, John R.
- Open AccessIntracellular Calcium Mobilization in Response to Ion Channel Regulators via a Calcium-Induced Calcium Release MechanismTerry Petrou, Hervør L. Olsen, Christopher Thrasivoulou, John R. Masters, Jonathan F. Ashmore and Aamir AhmedJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 378-387; DOI: https://doi.org/10.1124/jpet.116.236695
McKinsey, Timothy A.
- You have accessTryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary HypertensionRobert J. Aiello, Patricia-Ann Bourassa, Qing Zhang, Jeffrey Dubins, Daniel R. Goldberg, Stéphane De Lombaert, Marc Humbert, Christophe Guignabert, Maria A. Cavasin, Timothy A. McKinsey and Vishwas ParalkarJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 267-279; DOI: https://doi.org/10.1124/jpet.116.237933
Meyer, Rainer
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
Minervini, Vanessa
- You have accessBehavioral Characterization of κ Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in RatsVanessa Minervini, Sujata Dahal and Charles P. FranceJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 280-287; DOI: https://doi.org/10.1124/jpet.116.235630
Minuesa, Gerard
- You have accessResponse to “Tenofovir Disoproxil Fumarate Is Not an Inhibitor of Human Organic Cation Transporter 1”Gerard Minuesa, Christopher Albert, Marçal Pastor-Anglada, Javier Martinez-Picado and Hermann KoepsellJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 343-345; DOI: https://doi.org/10.1124/jpet.116.239004
Mohr, Klaus
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
Murataeva, Natalia
- You have accessTwo Janus Cannabinoids That Are Both CB2 Agonists and CB1 AntagonistsAmey Dhopeshwarkar, Natalia Murataeva, Alex Makriyannis, Alex Straiker and Ken MackieJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 300-311; DOI: https://doi.org/10.1124/jpet.116.236539
N
Nagabukuro, H.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Newton, Robert
- You have accessGS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial CellsTaruna Joshi, Dong Yan, Omar Hamed, Stacey L. Tannheimer, Gary B. Phillips, Clifford D. Wright, Musong Kim, Michael Salmon, Robert Newton and Mark A. GiembyczJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 324-340; DOI: https://doi.org/10.1124/jpet.116.237743
O
O’Neill, Charles A.
- You have accessReveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe DiseaseJeffrey Peng, Jill Dalton, Mark Butt, Kristin Tracy, Derek Kennedy, Peter Haroldsen, Rhea Cahayag, Stephen Zoog, Charles A. O’Neill and Laurie S. TsurudaJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 313-323; DOI: https://doi.org/10.1124/jpet.116.235952
Olsen, Hervør L.
- Open AccessIntracellular Calcium Mobilization in Response to Ion Channel Regulators via a Calcium-Induced Calcium Release MechanismTerry Petrou, Hervør L. Olsen, Christopher Thrasivoulou, John R. Masters, Jonathan F. Ashmore and Aamir AhmedJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 378-387; DOI: https://doi.org/10.1124/jpet.116.236695
P
Paralkar, Vishwas
- You have accessTryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary HypertensionRobert J. Aiello, Patricia-Ann Bourassa, Qing Zhang, Jeffrey Dubins, Daniel R. Goldberg, Stéphane De Lombaert, Marc Humbert, Christophe Guignabert, Maria A. Cavasin, Timothy A. McKinsey and Vishwas ParalkarJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 267-279; DOI: https://doi.org/10.1124/jpet.116.237933
Pastor-Anglada, Marçal
- You have accessResponse to “Tenofovir Disoproxil Fumarate Is Not an Inhibitor of Human Organic Cation Transporter 1”Gerard Minuesa, Christopher Albert, Marçal Pastor-Anglada, Javier Martinez-Picado and Hermann KoepsellJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 343-345; DOI: https://doi.org/10.1124/jpet.116.239004
Patten, Glen Stephen
- Open AccessEffects of Antihypertensive Agents on Intestinal Contractility in the Spontaneously Hypertensive Rat: Angiotensin Receptor System Downregulation by LosartanGlen Stephen Patten and Mahinda Yapa AbeywardenaJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 260-266; DOI: https://doi.org/10.1124/jpet.116.237586
Peng, Jeffrey
- You have accessReveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe DiseaseJeffrey Peng, Jill Dalton, Mark Butt, Kristin Tracy, Derek Kennedy, Peter Haroldsen, Rhea Cahayag, Stephen Zoog, Charles A. O’Neill and Laurie S. TsurudaJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 313-323; DOI: https://doi.org/10.1124/jpet.116.235952
Pereira, A.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Petrou, Terry
- Open AccessIntracellular Calcium Mobilization in Response to Ion Channel Regulators via a Calcium-Induced Calcium Release MechanismTerry Petrou, Hervør L. Olsen, Christopher Thrasivoulou, John R. Masters, Jonathan F. Ashmore and Aamir AhmedJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 378-387; DOI: https://doi.org/10.1124/jpet.116.236695
Phillips, Gary B.
- You have accessGS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial CellsTaruna Joshi, Dong Yan, Omar Hamed, Stacey L. Tannheimer, Gary B. Phillips, Clifford D. Wright, Musong Kim, Michael Salmon, Robert Newton and Mark A. GiembyczJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 324-340; DOI: https://doi.org/10.1124/jpet.116.237743
Ploeger, Bart A.
- You have accessCharacterization and Prediction of Cardiovascular Effects of Fingolimod and Siponimod Using a Systems Pharmacology Modeling ApproachNelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Dean F. Rigel, Randy L. Webb, David Feldman, Fumin Fu, Michael Beil, Liang Jin, Donald R. Stanski and Meindert DanhofJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 356-367; DOI: https://doi.org/10.1124/jpet.116.236208
R
Racké, Kurt
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
Rigel, Dean F.
- You have accessCharacterization and Prediction of Cardiovascular Effects of Fingolimod and Siponimod Using a Systems Pharmacology Modeling ApproachNelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Dean F. Rigel, Randy L. Webb, David Feldman, Fumin Fu, Michael Beil, Liang Jin, Donald R. Stanski and Meindert DanhofJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 356-367; DOI: https://doi.org/10.1124/jpet.116.236208
Roth, Robert A.
- You have accessIdiosyncratic Drug-Induced Liver Injury: Is Drug-Cytokine Interaction the Linchpin?Robert A. Roth, Ashley R. Maiuri and Patricia E. GaneyJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 368-377; DOI: https://doi.org/10.1124/jpet.116.237578
S
Salituro, G.M.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Salmon, Michael
- You have accessGS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial CellsTaruna Joshi, Dong Yan, Omar Hamed, Stacey L. Tannheimer, Gary B. Phillips, Clifford D. Wright, Musong Kim, Michael Salmon, Robert Newton and Mark A. GiembyczJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 324-340; DOI: https://doi.org/10.1124/jpet.116.237743
Sanfiz, A.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Sasse, Philipp
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
Schlicker, Eberhard
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
Schrage, Ramona
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
Seemann, Wiebke K.
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
Sen, Tuhinadri
- You have accessAllylpyrocatechol Attenuates Collagen-Induced Arthritis via Attenuation of Oxidative Stress Secondary to Modulation of the MAPK, JAK/STAT, and Nrf2/HO-1 PathwaysSoumita De, Alak Manna, Sunanda Kundu, Sritama De Sarkar, Uttara Chatterjee, Tuhinadri Sen, Subrata Chattopadhyay and Mitali ChatterjeeJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 249-259; DOI: https://doi.org/10.1124/jpet.116.238444
Shen, Hong
- You have accessTenofovir Disoproxil Fumarate Is Not an Inhibitor of Human Organic Cation Transporter 1Hong Shen, Wenying Li, W. Griffith Humphreys and Yurong LaiJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 341-342; DOI: https://doi.org/10.1124/jpet.116.238337
Snelder, Nelleke
- You have accessCharacterization and Prediction of Cardiovascular Effects of Fingolimod and Siponimod Using a Systems Pharmacology Modeling ApproachNelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Dean F. Rigel, Randy L. Webb, David Feldman, Fumin Fu, Michael Beil, Liang Jin, Donald R. Stanski and Meindert DanhofJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 356-367; DOI: https://doi.org/10.1124/jpet.116.236208
Stanski, Donald R.
- You have accessCharacterization and Prediction of Cardiovascular Effects of Fingolimod and Siponimod Using a Systems Pharmacology Modeling ApproachNelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Dean F. Rigel, Randy L. Webb, David Feldman, Fumin Fu, Michael Beil, Liang Jin, Donald R. Stanski and Meindert DanhofJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 356-367; DOI: https://doi.org/10.1124/jpet.116.236208
Straiker, Alex
- You have accessTwo Janus Cannabinoids That Are Both CB2 Agonists and CB1 AntagonistsAmey Dhopeshwarkar, Natalia Murataeva, Alex Makriyannis, Alex Straiker and Ken MackieJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 300-311; DOI: https://doi.org/10.1124/jpet.116.236539
Struthers, M.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
T
Tannheimer, Stacey L.
- You have accessGS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial CellsTaruna Joshi, Dong Yan, Omar Hamed, Stacey L. Tannheimer, Gary B. Phillips, Clifford D. Wright, Musong Kim, Michael Salmon, Robert Newton and Mark A. GiembyczJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 324-340; DOI: https://doi.org/10.1124/jpet.116.237743
Thrasivoulou, Christopher
- Open AccessIntracellular Calcium Mobilization in Response to Ion Channel Regulators via a Calcium-Induced Calcium Release MechanismTerry Petrou, Hervør L. Olsen, Christopher Thrasivoulou, John R. Masters, Jonathan F. Ashmore and Aamir AhmedJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 378-387; DOI: https://doi.org/10.1124/jpet.116.236695
Tracy, Kristin
- You have accessReveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe DiseaseJeffrey Peng, Jill Dalton, Mark Butt, Kristin Tracy, Derek Kennedy, Peter Haroldsen, Rhea Cahayag, Stephen Zoog, Charles A. O’Neill and Laurie S. TsurudaJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 313-323; DOI: https://doi.org/10.1124/jpet.116.235952
Tsuruda, Laurie S.
- You have accessReveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe DiseaseJeffrey Peng, Jill Dalton, Mark Butt, Kristin Tracy, Derek Kennedy, Peter Haroldsen, Rhea Cahayag, Stephen Zoog, Charles A. O’Neill and Laurie S. TsurudaJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 313-323; DOI: https://doi.org/10.1124/jpet.116.235952
V
Vakalopoulos, Costa
- You have accessThe Glutamate Model of Schizophrenia: It’s All About Signal Muscarinic ConnectionsCosta VakalopoulosJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 288; DOI: https://doi.org/10.1124/jpet.116.238766
Veronin, G.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Villa, K.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
W
Warnken, Mareille
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
Webb, Randy L.
- You have accessCharacterization and Prediction of Cardiovascular Effects of Fingolimod and Siponimod Using a Systems Pharmacology Modeling ApproachNelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Dean F. Rigel, Randy L. Webb, David Feldman, Fumin Fu, Michael Beil, Liang Jin, Donald R. Stanski and Meindert DanhofJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 356-367; DOI: https://doi.org/10.1124/jpet.116.236208
Weber, A. E.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Wenzel, Daniela
- You have accessEngineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled ReceptorWiebke K. Seemann, Daniela Wenzel, Ramona Schrage, Justine Etscheid, Theresa Bödefeld, Anna Bartol, Mareille Warnken, Philipp Sasse, Jessica Klöckner, Ulrike Holzgrabe, Marco DeAmici, Eberhard Schlicker, Kurt Racké, Evi Kostenis, Rainer Meyer, Bernd K. Fleischmann and Klaus MohrJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 289-299; DOI: https://doi.org/10.1124/jpet.116.237149
Wickham, L. A.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Woods, J.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Wright, Clifford D.
- You have accessGS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial CellsTaruna Joshi, Dong Yan, Omar Hamed, Stacey L. Tannheimer, Gary B. Phillips, Clifford D. Wright, Musong Kim, Michael Salmon, Robert Newton and Mark A. GiembyczJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 324-340; DOI: https://doi.org/10.1124/jpet.116.237743
Y
Yan, Dong
- You have accessGS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial CellsTaruna Joshi, Dong Yan, Omar Hamed, Stacey L. Tannheimer, Gary B. Phillips, Clifford D. Wright, Musong Kim, Michael Salmon, Robert Newton and Mark A. GiembyczJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 324-340; DOI: https://doi.org/10.1124/jpet.116.237743
Z
Zamlynny, B.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Zhang, Qing
- You have accessTryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary HypertensionRobert J. Aiello, Patricia-Ann Bourassa, Qing Zhang, Jeffrey Dubins, Daniel R. Goldberg, Stéphane De Lombaert, Marc Humbert, Christophe Guignabert, Maria A. Cavasin, Timothy A. McKinsey and Vishwas ParalkarJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 267-279; DOI: https://doi.org/10.1124/jpet.116.237933
Zoog, Stephen
- You have accessReveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe DiseaseJeffrey Peng, Jill Dalton, Mark Butt, Kristin Tracy, Derek Kennedy, Peter Haroldsen, Rhea Cahayag, Stephen Zoog, Charles A. O’Neill and Laurie S. TsurudaJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 313-323; DOI: https://doi.org/10.1124/jpet.116.235952
Zycband, E.
- You have accessPharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. StruthersJournal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
In this issue
Advertisement